Tumor markers and multimodal magnetic resonance imaging in predicting rectal cancer stage and differentiation

doi:10.4251/wjgo.v17.i8.108007

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-8) series.

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-8)

Sum=0

Aug 15, 2025 (publication date) through Aug 14, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Aug 15, 2025; 17(8): 108007
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.108007

Open in New Tab Full Size Figure Download Figure

Figure 1 Patient selection flowchart. MRI: Magnetic resonance imaging.

Open in New Tab Full Size Figure Download Figure

Figure 2 Receiver operating characteristic curve assessing the diagnostic efficacy of tumor markers combined with magnetic resonance imaging. A: Receiver operating characteristic curve assessing the diagnostic efficacy tumor markers combined with magnetic resonance imaging in preoperative T stage of rectal cancer; B: Receiver operating characteristic curve assessing the diagnostic efficacy of tumor markers combined with magnetic resonance imaging in rectal cancer differentiation. AFP: Alpha-fetoprotein; MRI: Magnetic resonance imaging; CA72-4: Cancer antigen 72-4; CA19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen.

Citation: Wang P, Han J, Zhao WN, Wu F, Zhang SH, Huang YJ. Tumor markers and multimodal magnetic resonance imaging in predicting rectal cancer stage and differentiation. World J Gastrointest Oncol 2025; 17(8): 108007
URL: https://www.wjgnet.com/1948-5204/full/v17/i8/108007.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i8.108007